The story
Since its creation in 1987 by Christian Diehl, a pharmacist based in Bourg-en-Bresse, France, Isispharma Laboratory has focused its research on the natural balance – homeostasis – and the imbalances of the skin to develop innovative and effective solutions to help each patient suffering from skin problems regain healthy skin.
Pioneering in the treatment of specific skin disorders such as hyperpigmentation, rosacea, and vitiligo, Isispharma quickly became renowned among dermatologists and patients for the efficacy of its solutions.
Since it was acquired in 2002 by the DEWAVRIN Group, a family-owned business specialized in the health and beauty industry, the laboratory has accelerated its international expansion while continuing to develop innovative and effective solutions.
Today, Isispharma’s skincare products are recommended by over 14,000 dermatologists in 80 countries.
-
1987
Creation of Isis Laboratory by Christian Diehl in Bourg en Bresse, France. -
1987 – 2002
Development of Unitone, Ruboril and Vitiskin formulas and export to various countries. -
2002
Laboratory is acquired by the DEWAVRIN Group, a family-owned business specialized in the health and beauty industry. -
2002-2010
Export development speeds up. -
2010
Creation of Neotone range, new generation of skincare for dark spots. -
2014
Isispharma expands and moves to its new headquarters in the center of Lyon, France. -
2015
Release of Metroruboril AZ, first skincare product specialized in severe redness. -
2016
Collaboration with the French National Center for Scientific Research (CNRS) in Lyon to improve knowledge of skin homeostasis. -
2018
Creation of Xerolan spray for severe and localized xerosis. -
2019
Publication in JEADV (Major dermatology journal) of the clinical study Neotone vs 4% hydroquinone.